Validation studies of J apanese administrative health care data: A scoping review
Pharmacoepidemiology and Drug Safety · 2023-07 · 32 (7) · 705-717
DOI: 10.1002/pds.5636 ↗Kurz gefasst
Scoping Review in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 14.05.2023. Verfasst von Hayato Yamana und 2 weiteren Autor:innen. Beteiligte Einrichtung: Data Science Center, Jichi Medical University, Shimotsuke, Japan. Hauptthemen laut MEDLINE: East Asian People. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Purpose
Large‐scale administrative health care databases are increasingly being utilized for research. However, there has not been much literature that validated administrative data in Japan; a previous review identified six validation studies published between 2011 and 2017. We conducted a literature review of studies that assessed the validity of Japanese administrative health care data.
Methods
We searched for studies published by March 2022 that compared individual‐level administrative data with a reference standard from another data source, as well as studies that validated administrative data using other data within the same database. The eligible studies were also summarized based on characteristics which included data types, settings, reference standard used, numbers of patients, and conditions validated.
Results
There were 36 eligible studies, including 29 that used external reference standard and seven that validated administrative data using other data within the same database. Chart review was the reference standard in 21 studies (range of the numbers of patients, 72–1674; 11 studies conducted in single institutions and nine studies in 2–5 institutions). Five studies used a disease registry as the reference standard. Diagnoses of cardiovascular diseases, cancer, and diabetes were frequently evaluated.
Conclusions
Validation studies are being conducted at an increasing rate in Japan, although most of them are small scale. Further large‐scale comprehensive validation studies are necessary to effectively utilize the databases for research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Data Science Center, Jichi Medical University, Shimotsuke, Japan.
- Department of Clinical Data Management and Research, Clinical Research Center, National Hospital Organization Headquarters, Meguro, Japan.
- Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Bunkyo, Japan.
- Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Bunkyo, Japan.
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
Zitieren
APA
Yamana, H., Konishi, T., & Yasunaga, H. (2023). Validation studies of J apanese administrative health care data: A scoping review. Pharmacoepidemiology and Drug Safety, 32(7), 705-717. https://doi.org/10.1002/pds.5636
Vancouver
Yamana H, Konishi T, Yasunaga H. Validation studies of J apanese administrative health care data: A scoping review. Pharmacoepidemiology and Drug Safety. 2023;32(7):705-717. doi:10.1002/pds.5636
BibTeX
@article{Yamana2023,
author = {Yamana, Hayato and Konishi, Takaaki and Yasunaga, Hideo},
title = {Validation studies of J apanese administrative health care data: A scoping review},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2023},
volume = {32},
number = {7},
pages = {705--717},
doi = {10.1002/pds.5636}
}
EUVIMED